MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window. [electronic resource]
Producer: 20060123Description: 612-5 p. digitalISSN:- 1526-632X
- Abciximab
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Anticoagulants -- administration & dosage
- Brain -- drug effects
- Brain Ischemia -- diagnosis
- Cerebral Arteries -- drug effects
- Female
- Humans
- Immunoglobulin Fab Fragments -- administration & dosage
- Infusions, Intravenous
- Intracranial Hemorrhages -- chemically induced
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Patient Selection
- Stroke -- diagnosis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.